These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1201104)

  • 1. Development of antibodies to ribonucleoprotein following short-term therapy with procainamide.
    Winfield JB; Koffler D; Kunkel HG
    Arthritis Rheum; 1975; 18(6):531-4. PubMed ID: 1201104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of antiribonucleoprotein antibodies in systemic lupus erythematosus.
    Bresnihan B; Grigor R; Hughes GR
    Ann Rheum Dis; 1977 Dec; 36(6):557-9. PubMed ID: 596947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide.
    Gold EF; Ben-Efraim S; Faivisewitz A; Steiner Z; Klajman A
    Clin Immunol Immunopathol; 1977 Mar; 7(2):176-86. PubMed ID: 301077
    [No Abstract]   [Full Text] [Related]  

  • 4. The measurement of antibodies to extractable nuclear antigen.
    Dorsch CA; White GM; Berzofsky RN
    Am J Clin Pathol; 1979 Mar; 71(3):333-7. PubMed ID: 107791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus.
    Weisbart RH; Yee WS; Colburn KK; Whang SH; Heng MK; Boucek RJ
    Ann Intern Med; 1986 Mar; 104(3):310-3. PubMed ID: 3511820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies as indicators for the procainamide-induced systemic lupus erythematosus-like syndrome and its clinical presentations.
    Gorsulowsky DC; Bank PW; Goldberg AD; Lee TG; Heinzerling RH; Burnham TK
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):245-53. PubMed ID: 3882781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.
    Lahita R; Kluger J; Drayer DE; Koffler D; Reidenberg MM
    N Engl J Med; 1979 Dec; 301(25):1382-5. PubMed ID: 91972
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in sera from patients receiving procainamide.
    Becker M; Klajman A; Moalem T; Yaretzky A; Ben-Efraim S
    Clin Immunol Immunopathol; 1979 Feb; 12(2):220-7. PubMed ID: 311265
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characterization of a new nuclear antigen using a human serum containing antinuclear antibodies (author's transl)].
    Barque JP; Yéni P; Péraudeau L; Signoret Y; Danon F; Larsen CJ
    C R Seances Acad Sci III; 1982 Mar; 294(12):563-6. PubMed ID: 6809233
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis.
    Bresnihan B; Bunn C; Snaith ML; Hughes GR
    Br Med J; 1977 Mar; 1(6061):610-1. PubMed ID: 843832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH; Persellin RH
    Arthritis Rheum; 1976; 19(5):851-6. PubMed ID: 786296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1.
    Savouret JF; Chudwin DS; Wara DW; Ammann AJ; Cowan MJ; Miller WL
    J Pediatr; 1983 Jun; 102(6):841-6. PubMed ID: 6189985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of combined treatment with lignocaine, procainamide and practolol in acute myocardial infarction.
    Nordlander R; Nyquist O
    Cardiology; 1980; 66(1):27-42. PubMed ID: 7388852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies to nucleoprotein conjugated with procainamide after procainamide treatment].
    Manor Y; Parksh R; Klajman A; Ben-Efraim S
    Harefuah; 1972 Apr; 82(7):304-6. PubMed ID: 4557588
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus.
    Totoritis MC; Tan EM; McNally EM; Rubin RL
    N Engl J Med; 1988 Jun; 318(22):1431-6. PubMed ID: 3259287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML; Dawkins B; Dawkins RL; Owen ET
    Ann Rheum Dis; 1979 Feb; 38(1):74-8. PubMed ID: 312058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.
    Karlsson E
    Br Heart J; 1975 Jul; 37(7):731-40. PubMed ID: 1098684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.